Bio-Techne

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$295,877
$286,555
$316,964
$316,181
Gross Profit
191,277
188,112
198,812
214,556
EBITDA
77,664
75,265
6,430
67,852
EBIT
52,955
50,925
-20,681
40,281
Net Income
38,009
38,185
-17,678
22,588
Net Change In Cash
295,877
286,555
316,964
316,181
Free Cash Flow
76,490
22,222
93,311
30,997
Cash
172,879
144,962
162,186
140,670
Basic Shares
156,999
156,362
155,757
158,944

Annual Financials

Values in thousands2025-06-302024-06-302023-06-302022-06-30
Revenue
$1,219,635
$1,159,060
$1,136,702
$1,105,599
Gross Profit
790,272
769,725
769,815
756,496
EBITDA
216,875
313,136
457,112
413,764
EBIT
106,972
201,425
349,874
312,695
Net Income
73,400
168,105
285,263
272,051
Net Change In Cash
1,219,635
1,159,060
1,136,702
1,105,599
Cost of Revenue
11,360
-14,432
Free Cash Flow
256,550
236,104
216,149
280,364
Cash
162,186
151,791
180,571
172,567
Basic Shares
159,717
160,774
161,855
164,116

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.46
2025-09-30
$0.42
2025-06-30
$0.53